Works matching AU Bairey, Osnat

Results: 57
    1
    2
    3
    4

    Efficacy of front‐line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter "Real‐World" study.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 2, p. E24, doi. 10.1002/ajh.26779
    By:
    • Levi, Shai;
    • Bronstein, Yotam;
    • Goldschmidt, Neta;
    • Morabito, Fortunato;
    • Ziv‐Baran, Tomer;
    • Del Poeta, Giovanni;
    • Bairey, Osnat;
    • Del Principe, Maria Ilaria;
    • Fineman, Riva;
    • Mauro, Francesca Romana;
    • Gutwein, Odit;
    • Reda, Gianluigi;
    • Ruchlemer, Rosa;
    • Sportoletti, Paolo;
    • Laurenti, Luca;
    • Shvidel, Lev;
    • Coscia, Marta;
    • Tadmor, Tamar;
    • Varettoni, Marzia;
    • Aviv, Ariel
    Publication type:
    Article
    5

    Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 6, p. 604, doi. 10.1002/ajh.25766
    By:
    • Herishanu, Yair;
    • Shaulov, Adir;
    • Fineman, Riva;
    • Bašić‐Kinda, Sandra;
    • Aviv, Ariel;
    • Wasik‐Szczepanek, Ewa;
    • Jaksic, Ozren;
    • Zdrenghea, Mihnea;
    • Greenbaum, Uri;
    • Mandac, Inga;
    • Simkovic, Martin;
    • Morawska, Marta;
    • Benjamini, Ohad;
    • Spacek, Martin;
    • Nemets, Anatoly;
    • Bairey, Osnat;
    • Trentin, Livio;
    • Ruchlemer, Rosa;
    • Laurenti, Luca;
    • Stanca Ciocan, Oana
    Publication type:
    Article
    6
    7

    Single‐agent ibrutinib versus chemoimmunotherapy regimens for treatment‐naïve patients with chronic lymphocytic leukemia: A cross‐trial comparison of phase 3 studies.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 11, p. 1402, doi. 10.1002/ajh.25259
    By:
    • Robak, Tadeusz;
    • Burger, Jan A.;
    • Tedeschi, Alessandra;
    • Barr, Paul M.;
    • Owen, Carolyn;
    • Bairey, Osnat;
    • Hillmen, Peter;
    • Simpson, David;
    • Grosicki, Sebastian;
    • Devereux, Stephen;
    • McCarthy, Helen;
    • Coutre, Steven E.;
    • Quach, Hang;
    • Gaidano, Gianluca;
    • Maslyak, Zvenyslava;
    • Stevens, Don A.;
    • Moreno, Carol;
    • Gill, Devinder S.;
    • Flinn, Ian W.;
    • Gribben, John G.
    Publication type:
    Article
    8

    Richter's transformation to diffuse large B-cell lymphoma: A retrospective study reporting clinical data, outcome, and the benefit of adding rituximab to chemotherapy, from the Israeli CLL Study Group.

    Published in:
    American Journal of Hematology, 2014, v. 89, n. 11, p. E218, doi. 10.1002/ajh.23826
    By:
    • Tadmor, Tamar;
    • Shvidel, Lev;
    • Bairey, Osnat;
    • Goldschmidt, Neta;
    • Ruchlemer, Rosa;
    • Fineman, Riva;
    • Rahimi-Levene, Naomi;
    • Herishanu, Yair;
    • Yuklea, Mona;
    • Arad, Ariela;
    • Aviv, Ariel;
    • Polliack, Aaron
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16

    P1122: A PROSPECTIVE, NON-INTERVENTIONAL STUDY OF REAL-WORLD TREATMENT AND OUTCOME IN SECONDARY CNS LYMPHOMA.

    Published in:
    2023
    By:
    • Habringer, Stefan;
    • Demel, Uta;
    • Fietz, Anne-Katrin;
    • Lammer, Felicitas;
    • Schroers, Roland;
    • Hofer, Silvia;
    • Bairey, Osnat;
    • Braess, Jan;
    • Sofia Meier-Stiegen, Anna;
    • Stuhlmann, Reingard;
    • Schmidt-Hieber, Martin;
    • Hoffmann, Johannes;
    • Zinngrebe, Bettina;
    • Kaiser, Ulrich;
    • Reimer, Peter;
    • Möhle, Robert;
    • Fix, Peter;
    • Höffkes, Heinz-Gert;
    • Langenkamp, Ulrich;
    • Büschenfelde, Christian Meyer Zum
    Publication type:
    Abstract
    17
    18

    Up to 6.5 years (median 4 years) of follow-up of first-line ibrutinib in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma and high-risk genomic features: integrated analysis of two phase 3 studies.

    Published in:
    Leukemia & Lymphoma, 2022, v. 63, n. 6, p. 1375, doi. 10.1080/10428194.2021.2020779
    By:
    • Burger, Jan A.;
    • Robak, Tadeusz;
    • Demirkan, Fatih;
    • Bairey, Osnat;
    • Moreno, Carol;
    • Simpson, David;
    • Munir, Talha;
    • Stevens, Don A.;
    • Dai, Sandra;
    • Cheung, Leo W. K.;
    • Kwei, Kevin;
    • Lal, Indu;
    • Hsu, Emily;
    • Kipps, Thomas J.;
    • Tedeschi, Alessandra
    Publication type:
    Article
    19
    20

    Abstracts from the 5th International Workshop on Positron Emission Tomography in Lymphoma held in Menton, France, 19-20 September 2014.

    Published in:
    Leukemia & Lymphoma, 2015, v. 56, n. 5, p. 1233, doi. 10.3109/10428194.2015.1034707
    By:
    • Zwarthoed, Cholette;
    • Ouvier, Matthieu John;
    • Borra, Anna;
    • Bergesio, Fabrizio;
    • Chauvie, Stephane;
    • Biggi, Alberto;
    • Hutchings, Martin;
    • El-Galaly, Tarek;
    • Gallamini, Andrea;
    • Simon, Zsófia;
    • Miltényi, Zsófia;
    • Magyari, Ferenc;
    • Barna, Sándor;
    • Kenyeres, Anna;
    • Jóna, Ádám;
    • Illés, Árpád;
    • Dann, Eldad J.;
    • Bar-Shalom, Rachel;
    • Kagana, Olga;
    • Bairey, Osnat
    Publication type:
    Article
    21

    A phase 2 study of ibrutinib maintenance following first‐line high‐dose methotrexate‐based chemotherapy for elderly patients with primary central nervous system lymphoma.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 24, p. 3905, doi. 10.1002/cncr.34985
    By:
    • Bairey, Osnat;
    • Taliansky, Alisa;
    • Glik, Amir;
    • Amiel, Alexandra;
    • Yust‐Katz, Shlomit;
    • Gurion, Ronit;
    • Zektser, Miri;
    • Porges, Tzvika;
    • Sarid, Nadav;
    • Horowitz, Netanel A.;
    • Shina, Tzahala Tzuk;
    • Lebel, Eyal;
    • Cohen, Amos;
    • Geiger, Karyn Revital;
    • Raanani, Pia;
    • Wolach, Ofir;
    • Siegal, Tali
    Publication type:
    Article
    22

    The addition of rituximab to anthracycline-based chemotherapy significantly improves outcome in ‘Western’ patients with intravascular large B-cell lymphoma.

    Published in:
    British Journal of Haematology, 2008, v. 143, n. 2, p. 253, doi. 10.1111/j.1365-2141.2008.07338.x
    By:
    • Ferreri, Andrés J. M.;
    • Dognini, Giuseppina P.;
    • Bairey, Osnat;
    • Szomor, Arpad;
    • Montalbán, Carlos;
    • Horvath, Barbara;
    • Demeter, Judit;
    • Uziel, Lilj;
    • Soffietti, Riccardo;
    • Seymour, John F.;
    • Ambrosetti, Achille;
    • Willemze, Rein;
    • Martelli, Maurizio;
    • Rossi, Giuseppe;
    • Candoni, Anna;
    • De Renzo, Amalia;
    • Doglioni, Claudio;
    • Zucca, Emanuele;
    • Cavalli, Franco;
    • Ponzoni, Maurilio
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41

    Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET/ CT is beneficial: a prospective multicentre trial of 355 patients.

    Published in:
    British Journal of Haematology, 2017, v. 178, n. 5, p. 709, doi. 10.1111/bjh.14734
    By:
    • Dann, Eldad J.;
    • Bairey, Osnat;
    • Bar‐Shalom, Rachel;
    • Mashiach, Tanya;
    • Barzilai, Elinor;
    • Kornberg, Abraham;
    • Akria, Luiza;
    • Tadmor, Tamar;
    • Filanovsky, Kalman;
    • Abadi, Uri;
    • Kagna, Olga;
    • Ruchlemer, Rosa;
    • Abdah‐Bortnyak, Roxolyana;
    • Goldschmidt, Neta;
    • Epelbaum, Ron;
    • Horowitz, Netanel A.;
    • Lavie, David;
    • Ben‐Yehuda, Dina;
    • Shpilberg, Ofer;
    • Paltiel, Ora
    Publication type:
    Article
    42
    43
    44

    CLL-045: Long-Term Follow-up, Up to 7 Years, in the RESONATE-2 Study of First-Line Ibrutinib Treatment for Chronic Lymphocytic Leukemia (CLL).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S316, doi. 10.1016/S2152-2650(21)01747-X
    By:
    • Burger, Jan;
    • Barr, Paul;
    • Owen, Carolyn;
    • Robak, Tadeusz;
    • Tedeschi, Alessandra;
    • Bairey, Osnat;
    • Hillmen, Peter;
    • Coutre, Steve;
    • Devereux, Stephen;
    • Grosicki, Sebastian;
    • McCarthy, Helen;
    • Li, Jianyong;
    • Offner, Fritz;
    • Moreno, Carol;
    • Dai, Sandra;
    • Szoke, Anita;
    • Dean, James P.;
    • Kipps, Thomas J.;
    • Ghia, Paolo
    Publication type:
    Article
    45

    Poster: CLL-045: Long-Term Follow-up, Up to 7 Years, in the RESONATE-2 Study of First-Line Ibrutinib Treatment for Chronic Lymphocytic Leukemia (CLL).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S221, doi. 10.1016/S2152-2650(21)01393-8
    By:
    • Burger, Jan;
    • Barr, Paul;
    • Owen, Carolyn;
    • Robak, Tadeusz;
    • Tedeschi, Alessandra;
    • Bairey, Osnat;
    • Hillmen, Peter;
    • Coutre, Steve;
    • Devereux, Stephen;
    • Grosicki, Sebastian;
    • McCarthy, Helen;
    • Jianyong Li;
    • Offner, Fritz;
    • Moreno, Carol;
    • Dai, Sandra;
    • Szoke, Anita;
    • Dean, James P.;
    • Kipps, Thomas J.;
    • Ghia, Paolo
    Publication type:
    Article
    46

    Five-Year Follow-Up After Ibrutinib Therapy for First-Line Treatment of Chronic Lymphocytic Leukemia.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S274, doi. 10.1016/j.clml.2019.07.205
    By:
    • Burger, Jan;
    • Tedeschi, Alessandra;
    • Barr, Paul M.;
    • Robak, Tadeusz;
    • Owen, Carolyn;
    • Ghia, Paolo;
    • Bairey, Osnat;
    • Hillmen, Peter;
    • Coutre, Steven E.;
    • Devereux, Stephen;
    • Grosicki, Sebastian;
    • McCarthy, Helen;
    • Li, Jianyong;
    • Simpson, David;
    • Offner, Fritz;
    • Moreno, Carol;
    • Dai, Sandra;
    • Lal, Indu;
    • Dean, James P.;
    • Kipps, Thomas J.
    Publication type:
    Article
    47

    Phase 3 Study of Ibrutinib versus Chlorambucil in Patients ≥65 Years with Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S45, doi. 10.1016/j.clml.2016.07.065
    By:
    • Burger, Jan;
    • Tedeschi, Alessandra;
    • Barr, Paul;
    • Robak, Tadeusz;
    • Owen, Carolyn;
    • Ghia, Paolo;
    • Bairey, Osnat;
    • Hillmen, Peter;
    • Bartlett, Nancy;
    • Li, Jianyong;
    • Simpson, David;
    • Grosicki, Sebastian;
    • Devereux, Stephen;
    • McCarthy, Helen;
    • Coutre, Steven;
    • Quach, Hang;
    • Gaidano, Gianluca;
    • Maslyak, Zvenyslava;
    • Stevens, Don;
    • Janssens, Ann
    Publication type:
    Article
    48

    Analysis of Quality of Life and Well-being from the Randomized Phase 3 Study of Ibrutinib Versus Chlorambucil in Older Patients with Treatment-naïve CLL (RESONATE-2TM).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S46, doi. 10.1016/j.clml.2016.07.066
    By:
    • Kipps, Thomas;
    • Ghia, Paolo;
    • Tedeschi, Alessandra;
    • Barr, Paul;
    • Robak, Tadeusz;
    • Owen, Carolyn;
    • Bairey, Osnat;
    • Hillmen, Peter;
    • Bartlett, Nancy;
    • Li, Jianyong;
    • Simpson, David;
    • Grosicki, Sebastian;
    • Deverux, Stephen;
    • McCarthy, Helen;
    • Coutre, Steven;
    • Offner, Fritz;
    • Moreno, Carol;
    • Zhou, Cathy;
    • Styles, Lori;
    • James, Danelle
    Publication type:
    Article
    49
    50

    Predictive value of the CLL‐IPI in CLL patients receiving chemo‐immunotherapy as first‐line treatment.

    Published in:
    European Journal of Haematology, 2018, v. 101, n. 5, p. 703, doi. 10.1111/ejh.13149
    By:
    • Gentile, Massimo;
    • Shanafelt, Tait D.;
    • Mauro, Francesca Romana;
    • Reda, Gianluigi;
    • Rossi, Davide;
    • Laurenti, Luca;
    • Del Principe, Maria Ilaria;
    • Cutrona, Giovanna;
    • Angeletti, Ilaria;
    • Coscia, Marta;
    • Herishanu, Yair;
    • Chiarenza, Annalisa;
    • Molica, Stefano;
    • Ciolli, Stefania;
    • Goldschmidt, Neta;
    • Angrilli, Francesco;
    • Giordano, Annamaria;
    • Rago, Angela;
    • Bairey, Osnat;
    • Tripepi, Giovanni
    Publication type:
    Article